FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+4.36%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$228M
AUM Growth
+$228M
(-2%)
Cap. Flow
-$9.02M
Cap. Flow
% of AUM
-3.96%
Top 10 Holdings %
Top 10 Hldgs %
50.06%
Holding
75
New
7
Increased
21
Reduced
25
Closed
21
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$4.73M |
| 2 |
NeoGenomics
NEO
|
$4.64M |
| 3 |
SHPG
Shire pic
SHPG
|
$3.01M |
| 4 |
iShares Biotechnology ETF
IBB
|
$2.1M |
| 5 |
Bio-Techne
TECH
|
$1.52M |
Top Sells
| 1 |
Option Care Health
OPCH
|
$6.12M |
| 2 |
Orthofix Medical
OFIX
|
$5.87M |
| 3 |
CYNA
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
|
$4.76M |
| 4 |
ELGX
Endologix Inc
ELGX
|
$3.29M |
| 5 |
CPHD
Cepheid Inc
CPHD
|
$3.2M |
Sector Composition
| 1 | Healthcare | 77.84% |
| 2 | Energy | 4.42% |
| 3 | Communication Services | 1.49% |
| 4 | Real Estate | 1.27% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Novartis
NVS
$248B
| $260K | 0.11% |
3,572
-2,498
| -41% | -$182K |
|
52
Merck
MRK
$210B
| $253K | 0.11% |
4,294
-2,316
| -35% | -$136K |
|
53
Johnson & Johnson
JNJ
$429B
| $252K | 0.11% |
2,183
-1,637
| -43% | -$189K |
|
|
AVGR
54
DELISTED
Avinger, Inc. Common Stock
AVGR
| $164K | 0.07% |
-52,200
| Closed | -$461K |
|
|
BEAT
55
DELISTED
BioTelemetry, Inc.
BEAT
| – | – |
-94,993
| Closed | -$1.76M |
|
|
CYNA
56
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| – | – |
-118,349
| Closed | -$4.76M |
|
|
CPHD
57
DELISTED
Cepheid Inc
CPHD
| – | – |
-60,805
| Closed | -$3.2M |
|
|
AET
58
DELISTED
Aetna Inc
AET
| – | – |
-2,604
| Closed | -$301K |
|
|
ELGX
59
DELISTED
Endologix Inc
ELGX
| – | – |
-256,906
| Closed | -$3.29M |
|
|
AGN
60
DELISTED
Allergan plc
AGN
| – | – |
-2,035
| Closed | -$469K |
|
61
Viatris
VTRS
$12.3B
| – | – |
-9,775
| Closed | -$373K |
|
62
United Therapeutics
UTHR
$17.7B
| – | – |
-3,820
| Closed | -$451K |
|
63
Steris
STE
$23.9B
| – | – |
-6,330
| Closed | -$463K |
|
|
64
Option Care Health
OPCH
$4.7B
| – | – |
-2,118,759
| Closed | -$6.12M |
|
|
65
Orthofix Medical
OFIX
$583M
| – | – |
-137,212
| Closed | -$5.87M |
|
66
AstraZeneca
AZN
$255B
| – | – |
-11,360
| Closed | -$373K |
|
67
Amgen
AMGN
$153B
| – | – |
-2,330
| Closed | -$389K |
|
68
Agilent Technologies
A
$35.5B
| – | – |
-5,120
| Closed | -$241K |
|
69
Becton Dickinson
BDX
$54.3B
| – | – |
-3,395
| Closed | -$610K |
|
70
Bio-Rad Laboratories Class A
BIO
$7.8B
| – | – |
-1,675
| Closed | -$274K |
|
71
Bristol-Myers Squibb
BMY
$96.7B
| – | – |
-8,290
| Closed | -$447K |
|
72
Elevance Health
ELV
$72.4B
| – | – |
-2,047
| Closed | -$257K |
|
73
Humana
HUM
$37.5B
| – | – |
-1,768
| Closed | -$313K |
|
74
IRIDEX
IRIX
$23.6M
| – | – |
-10,311
| Closed | -$149K |
|
75
Eli Lilly
LLY
$661B
| – | – |
-5,495
| Closed | -$441K |
|